Get the Stockscreener App
59.58
0.13%
0.075
Longboard Pharmaceuticals Inc stock is traded at $59.58, with a volume of 236.50K.
It is up +0.13% in the last 24 hours and up +64.49% over the past month.
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.
See More
Previous Close:
$59.50
Open:
$59.58
24h Volume:
236.50K
Relative Volume:
0.15
Market Cap:
$2.32B
Revenue:
-
Net Income/Loss:
$-54.42M
P/E Ratio:
-23.35
EPS:
-2.5513
Net Cash Flow:
$-50.87M
1W Performance:
+0.02%
1M Performance:
+64.49%
6M Performance:
+178.74%
1Y Performance:
+979.35%
1-Day Range:
$59.40
$59.68
1-Week Range:
$58.82
$59.95
52-Week Range:
$3.60
$59.95
Longboard Pharmaceuticals Inc Stock (LBPH) Company Profile
Name
Longboard Pharmaceuticals Inc
Sector
Industry
Phone
619-592-9775
Address
4275 EXECUTIVE SQUARE, LA JOLLA
Longboard Pharmaceuticals Inc Stock (LBPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-24-23 | Resumed | Cantor Fitzgerald | Overweight |
| Apr-27-23 | Initiated | B. Riley Securities | Buy |
| Apr-07-21 | Initiated | Evercore ISI | Outperform |
| Apr-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-06-21 | Initiated | Citigroup | Buy |
| Apr-06-21 | Initiated | Guggenheim | Buy |
View All
Longboard Pharmaceuticals Inc Stock (LBPH) Latest News
Vanguard Group Inc's Strategic Acquisition in Longboard Pharmace - GuruFocus.com
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Position Increased by Emerald Advisers LLC - MarketBeat
Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year High – Here’s What Happened - Defense World
Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 52-Week HighShould You Buy? - MarketBeat
Longboard Pharmaceuticals stock soars to all-time high of $59.95 - Investing.com
Longboard Pharmaceuticals stock soars to all-time high of $59.95 By Investing.com - Investing.com Australia
Longboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings - TipRanks
LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc.LBPH - Business Wire
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of “Hold” by Analysts - Defense World
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - MSN
(LBPH) Trading Signals - Stock Traders Daily
Longboard Pharmaceuticals stock soars to all-time high of $59.48 By Investing.com - Investing.com Australia
Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year HighStill a Buy? - MarketBeat
Longboard Pharmaceuticals stock soars to all-time high of $59.48 - Investing.com India
$DRUG 5,900% Weekly Surge Turns Attention. Cybin ($CYBN) Rallying 23% This Week In Anticipation For Major Milestones - FinanceFeeds
Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? - Benzinga
The week in pharma: action, reaction and insight – week to October 19 | Pharmaceutical | The Pharmaletter - The Pharma Letter
Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company - MSN
Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion. - MSN
Longboard soars as Lundbeck to buy company for equity value of $2.6B - MSN
Longboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by Lundbeck - MSN
SG Americas Securities LLC Buys Shares of 10,514 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - MSN
Taxation With Representation: Baker, Simpson, Ropes - Law360
Longboard Pharmaceuticals CMO sells $983,936 in stock By Investing.com - Investing.com South Africa
Randall Kaye Sells 16,667 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Stock - MarketBeat
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc.LBPH - The Malaysian Reserve
Longboard Pharmaceuticals (NASDAQ:LBPH) Lowered to Hold at Wedbush - MarketBeat
Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52% - MSN
Lundbeck's billion-dollar acquisition will cost layoffs - MedWatch
Lundbeck to Acquire Longboard Pharmaceuticals - CHEManager
Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals - Global Legal Chronicle
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Update - MarketBeat
Lundbeck picks up Longboard Pharmaceuticals for $2.6B - MM+M Online
Longboard Pharmaceuticals downgraded to Neutral from Buy at B. Riley - TipRanks
Longboard Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
HC Wainwright Reiterates Neutral Rating for Longboard Pharmaceuticals (NASDAQ:LBPH) - MarketBeat
Longboard Pharma's Lucrative Exit To Lundbeck Another Coup For Management (NASDAQ:LBPH) - Seeking Alpha
Lundbeck Agrees To Acquire Longboard Pharmaceuticals - Contract Pharma
Longboard Pharma soars after announcing acquisition by Danish peer - Kursiv Media
Lundbeck Acquires Longboard Pharmaceuticals for $2.6 Billion - TipRanks
LBPH Stock Soars 51% as Lundbeck Acquires Longboard Pharmaceuticals for $2.6 Billion - MoneyCheck
Longboard Pharmaceuticals : Lundbeck to acquire Longboard Pharmaceuticals in a strategic deal, significantly enhancing its neuroscience pipeline Form 8 K - Marketscreener.com
Danish Lundbeck acquires American Longboard Pharmaceuticals for $2.6 billion - AK&M News
Denmark: Lundbeck to acquire Longboard Pharmaceuticals - Investors in Healthcare
Lundbeck agrees to acquire Longboard Pharma for $2.6bn - World Pharmaceutical Frontiers
Lundbeck forking out $2.6 billion to acquire Longboard Pharma | Biotechnology | The Pharmaletter - The Pharma Letter
Lundbeck to acquire Longboard Pharmaceuticals for $2.6bn - Pharmaceutical Technology
Longboard Pharmaceuticals' IPO Lock-up Period Ends On Sep. 8 - RTTNews
Longboard Pharmaceuticals Inc Stock (LBPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Longboard Pharmaceuticals Inc Stock (LBPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kaye Randall | CMO |
Oct 15 '24 |
Sale |
59.03 |
16,667 |
983,936 |
17,920 |
| Kaye Randall | CMO |
Sep 16 '24 |
Option Exercise |
4.35 |
16,666 |
72,497 |
34,586 |
| Kaye Randall | CMO |
Sep 16 '24 |
Sale |
31.64 |
16,666 |
527,318 |
17,920 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):